Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Alpine Immune Sciences Inc
(NQ:
ALPN
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EDT, May 17, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Alpine Immune Sciences Inc
< Previous
1
2
3
4
Next >
Navigating 8 Analyst Ratings For Alpine Immune Sciences
April 09, 2024
Via
Benzinga
Lamb Weston Reports Weak Earnings, Joins Paragon 28, Resources Connection And Other Big Stocks Moving Lower On Thursday
April 04, 2024
U.S. stocks were higher, with the Dow Jones gaining over 150 points on Thursday.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Peraso Shares Are Trading Lower By Over 23%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
March 19, 2024
Shares of Peraso Inc. (NASDAQ: PRSO) fell sharply during Tuesday’s session after the company reported worse-than-expected fourth-quarter EPS results.
Via
Benzinga
Evaluating Alpine Immune Sciences: Insights From 6 Financial Analysts
March 19, 2024
Via
Benzinga
Recap: Alpine Immune Sciences Q4 Earnings
March 18, 2024
Via
Benzinga
Preview: Alpine Immune Sciences's Earnings
March 15, 2024
Via
Benzinga
Alpine Immune Sciences Analysts Boost Their Forecasts After Q4 Earnings
March 19, 2024
Alpine Immune Sciences, Inc. (NASDAQ: ALPN) reported better-than-expected fourth-quarter financial results.
Via
Benzinga
National CineMedia Reports Upbeat Results, Joins Nordstrom, Core & Main And Other Big Stocks Moving Higher On Tuesday
March 19, 2024
U.S. stocks were mixed, with the Dow Jones index gaining around 75 points on Tuesday.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
ALPN Stock Earnings: Alpine Immune Sciences Beats EPS, Beats Revenue for Q4 2023
March 18, 2024
ALPN stock results show that Alpine Immune Sciences beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2023.
Via
InvestorPlace
Earnings Scheduled For March 18, 2024
March 18, 2024
Companies Reporting Before The Bell • Niu Techs (NASDAQ:NIU) is expected to report earnings for its fourth quarter.
Via
Benzinga
In-Depth Examination Of 6 Analyst Recommendations For Alpine Immune Sciences
January 26, 2024
Via
Benzinga
Beyond The Numbers: 7 Analysts Discuss Alpine Immune Sciences Stock
December 22, 2023
Via
Benzinga
The Latest Analyst Ratings for Alpine Immune Sciences
November 15, 2023
Via
Benzinga
Why Humana Shares Are Trading Lower By Over 11%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
January 25, 2024
Shares of Humana Inc. (NYSE: HUM) fell sharply during Thursday’s session after the company reported fourth-quarter FY23 earnings and issued 2024 guidance.
Via
Benzinga
Alaska Air Posts Upbeat Earnings, Joins Xerox, United Rentals And Other Big Stocks Moving Higher On Thursday
January 25, 2024
U.S. stocks traded higher, with the Dow Jones gaining around 50 points on Thursday. Shares of Alaska Air Group, Inc. (NYSE: ALK) rose during Thursday’s session following upbeat earnings.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
What 8 Analyst Ratings Have To Say About Alpine Immune Sciences
October 18, 2023
Via
Benzinga
Analyst Expectations for Alpine Immune Sciences's Future
August 31, 2023
Via
Benzinga
Tesla To Rally Around 38%? Here Are 10 Top Analyst Forecasts For Friday
December 22, 2023
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
Via
Benzinga
Why Sanmina Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
November 07, 2023
Gainers PaxMedica, Inc. (NASDAQ: PXMD) shares climbed 173.8% to $8.35. PaxMedica announced the publication of its autism spectrum disorder Phase 2 study results in the Annals of General Psychiatry.
Via
Benzinga
Recap: Alpine Immune Sciences Q1 Earnings
May 11, 2023
Via
Benzinga
Sanmina, Adtran, Ameresco And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
November 07, 2023
U.S. stock futures traded lower this morning on Tuesday. Here are some big stocks recording losses in today’s pre-market trading session.
Via
Benzinga
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet
November 03, 2023
The Benzinga Stock Whisper Index uses proprietary data to look at stocks with increased interest from investors.
Via
Benzinga
Apple, Coinbase Global, Fortinet And Other Big Stocks Moving Lower In Friday's Pre-Market Session
November 03, 2023
U.S. stock futures traded lower this morning on Friday. Here are some big stocks recording losses in today’s pre-market trading session.
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
November 02, 2023
Via
Benzinga
Why STAAR Surgical Shares Are Trading Lower By Around 16%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
November 02, 2023
Gainers OmniLit Acquisition Corp. (NASDAQ: OLIT) jumped 53.2% to $15.53. OmniLit announced that its merger with Syntec was approved by shareholders.
Via
Benzinga
Why Is Alpine Immune Sciences Stock Trading Higher Today?
November 02, 2023
Alpine Immune Sciences Inc (NASDAQ: ALPN) presented the first clinical data of povetacicept in autoimmune glomerulonephritis during a late-breaking session at the American Society of Nephrology
Via
Benzinga
Starbucks, Teleflex, Roku, Shopify And Other Big Stocks Moving Higher On Thursday
November 02, 2023
U.S. stocks traded higher, with the Dow Jones gaining more than 350 points on Thursday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Benzinga's Top Ratings Upgrades, Downgrades For October 18, 2023
October 18, 2023
Via
Benzinga
IgAN Treatment Market Worth Over $6B By 2032: Analyst Bearish On Povetacicept's Promising Role
October 05, 2023
RBC Capital Markets initiated coverage on Alpine Immune Sciences Inc (NASDAQ: ALPN), noting that the autoimmune disease market (over $165 billion) is meaningful for the company's lead candidate -...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 5, 2023
October 05, 2023
Via
Benzinga
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.